Michael J. Williams
Michael J. Williams has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Andrew Brunskill
Department of Process and Analytical Chemistry, Merck Research Laboratories , Rahway, New Jersey 07065, United States
1 shared publicationCheol K. Chung
Department of Process and Analytical Chemistry, Merck Research Laboratories , Rahway, New Jersey 07065, United States
1 shared publication- Jongrock Kong
Department of Process and Analytical Chemistry, Merck Research Laboratories , Rahway, New Jersey 07065, United States
1 shared publication Louis-Charles Campeau
Department of Process and Analytical Chemistry, Merck Research Laboratories , Rahway, New Jersey 07065, United States
1 shared publicationMark McLaughlin
Department of Process and Analytical Chemistry, Merck Research Laboratories , Rahway, New Jersey 07065, United States
1 shared publication
Latest Publications
- 28 April 2016
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 18 (9) , 1952-1955
The Discovery of Quinoxaline-Based Metathesis Catalysts from Synthesis of Grazoprevir (MK-5172)
Olefin metathesis (OM) is a reliable and practical synthetic methodology for challenging carbon–carbon bond formations. While existing catalysts can effect many of these transformations, the synthesis and development of new catalysts is essential to increase the application breadth of OM and to achieve improved catalyst activity. The unexpected initial discovery of a novel olefin metathesis catalyst derived from synthetic efforts toward the HCV therapeutic agent grazoprevir (MK-5172) is described. This initial finding has evolved into a class of tunable, shelf-stable ruthenium OM catalysts that are easily prepared and exhibit unique catalytic activity.
- 28 April 2016
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 18 (9) , 1952-1955
The Discovery of Quinoxaline-Based Metathesis Catalysts from Synthesis of Grazoprevir (MK-5172)
Olefin metathesis (OM) is a reliable and practical synthetic methodology for challenging carbon–carbon bond formations. While existing catalysts can effect many of these transformations, the synthesis and development of new catalysts is essential to increase the application breadth of OM and to achieve improved catalyst activity. The unexpected initial discovery of a novel olefin metathesis catalyst derived from synthetic efforts toward the HCV therapeutic agent grazoprevir (MK-5172) is described. This initial finding has evolved into a class of tunable, shelf-stable ruthenium OM catalysts that are easily prepared and exhibit unique catalytic activity.